Health TrialsbyHealthPanel

Subtransverse Process Interligamentary Plane Block Versus Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block for Analgesia in Pediatric Thoracotomy

ConditionsSubtransverse Process Interligamentary Plane BlockRhomboid Intercostal BlockSub-Serratus Plane BlockAnalgesiaPediatric Thoracotomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorTanta University

About this trial

This study aims to compare ultrasound guided subtransverse process interligamentary plane block versus rhomboid intercostal block combined with sub-serratus plane block for postoperative analgesia in pediatric thoracotomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pediatric patients between 6 to 12 years.

Both sexes.

American Society of Anesthesiologists (ASA) Physical Status I - II.

Scheduled for thoracic surgery with thoracotomy incision under general anesthesia.

Disqualifiers

Parents who refused regional anesthesia.

Patients were presented with advanced kidney, cardiac or liver diseases.

Coagulation and bleeding disorders.

Patients presented with skin or soft tissue infection at the proposed site of needle Insertion.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard intravenous analgesia

    Other intervention

    Patients will receive no block intervention and standard intravenous analgesia will be given.

  • Subtransverse process interligamentary plane block

    Other intervention

    Patients will receive ipsilateral ultrasound-guided subtransverse process interligamentary (STIL) plane block with bupivacaine 0.25% (0.5 mL/kg) after induction of general anesthesia.

  • Rhomboid intercostal block (RIB) combined with sub-serratus plan block group

    Other intervention

    Patients will receive ipsilateral ultrasound-guided rhomboid intercostal block (RIB) combined with sub-serratus plan block group with bupivacaine 0.25% (0.5mL/kg) after induction of general anesthesia.

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: Control GroupActive comparator 1 intervention
Group B: STIL blockExperimental treatment 1 intervention
Group C: RISS block groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Time to first rescue analgesia

Time to the first rescue analgesia will be recorded from the end of surgery till first dose of morphine adminstrated.

Time frame
24 hours postoperatively

Secondary outcomes

1

Degree of pain

Each patient will be instructed about postoperative pain assessment with VAS. VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed after surgery over 24 hours (30 minutes postoperative, 2, 4, 6, 12, 24 hours.

Time frame
24 hours postoperatively
2

Total Opioids consumption

Morphine 0.05 mg /kg IV will be given as rescue analgesia if VAS score ≥4, morphine dose will not exceed 0.3 mg/kg/day.

Time frame
24 hours postoperatively
3

Intraoperative fentanyl consumption

Fentanyl 0.5 μg/kg will be administrated in the case of inadequate analgesia that defined as an un explained increase of heart rate (HR) and/or mean arterial blood pressure (MAP) more than 20% above the preoperative values after exclusion of other causes.

Time frame
Intraoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov
Apply now